Introduction Semaglutide has rapidly gained recognition as a transformative medication in the treatment of type 2 diabetes and obesity. Initially developed for diabetes management, Semaglutide belongs to a class of drugs known as GLP-1 receptor agonists. These medications mimic the actions of a naturally occurring hormone in the body, glucagon-like https://cesarwadgj.national-wiki.com/1090266/semaglutide_a_revolutionary_treatment_for_diabetes_obesity_and_heart_health